HUMAN THERAPEUTIC AGENTS
Human therapeutic treatment compositions comprise at least two of a curcumin component, a harmine component, and an isovanillin component, and preferably all three in combination. The agents are effective for the treatment of human conditions, especially human cancers.
1 - 18 . (canceled)
19 . A therapeutic composition comprising therapeutically active components consisting essentially of curcumin and isovanillin, said curcumin and isovanillin being different
20 . The composition of claim 19 , said isovanillin being present in an amount greater than the amount of said curcumin.
21 . The composition of claim 20 , the weight amount of said isovanillin being from about 75-95% by weight, and the amount of said curcumin being from about 5-25% by weight, based upon the total weight of said curcumin and isovanillin in said composition being 100% by weight.
22 . The composition of claim 19 , wherein said isovanillin and curcumin are at least about 50% pure.
23 . The composition of claim 19 , wherein the composition exhibits therapeutic synergy.
24 . The composition of claim 19 , the weight ratio of said isovanillin to said curcumin being from about 0.5:1 to 25:1.
25 . The composition of claim 19 , said isovanillin being synthetically derived or derived from naturally occurring product(s) containing isovanillin which have been treated so that the treated naturally occurring product(s) contain at least about 25% by weight isovanillin.
26 . The composition of claim 19 , said curcumin being synthetically derived or derived from naturally occurring product s) containing curcumin which have been treated so that the treated naturally occurring product(s) contain at least about 25% by weight curcumin.
27 . The composition of claim 19 , said composition including one or more additional ingredients selected from the group consisting of preservatives, buffering agents, salts, carriers, and excipients.
28 . The composition of claim 19 , said composition being an anti-cancer composition.